Peptide and protein nanoparticle conjugates: versatile platforms for biomedical applications. (26th February 2018)

• Record Type: Journal Article
• Authors: Spicer, Christopher D.; Jumeaux, Coline; Gupta, Bakul; Stevens, Molly M.
• Is Part Of: Chemical Society reviews. Volume 47:Number 10(2018)
• Page Start: 3574
• Page End: 3620
• Publication Date: 2018-02-26
• Subjects: Chemistry -- Periodicals; 540
• DOI: 10.1039/c7cs00877e
• Languages: English
• ISSNs: 0306-0012

Abstract

Abstract : Peptide– and protein–nanoparticle conjugates have emerged as powerful tools for biomedical applications, enabling the treatment, diagnosis, and prevention of disease. Abstract : Peptide– and protein–nanoparticle conjugates have emerged as powerful tools for biomedical applications, enabling the treatment, diagnosis, and prevention of disease. In this review, we focus on the key roles played by peptides and proteins in improving, controlling, and defining the performance of nanotechnologies. Within this framework, we provide a comprehensive overview of the key sequences and structures utilised to provide biological and physical stability to nano-constructs, direct particles to their target and influence their cellular and tissue distribution, induce and control biological responses, and form polypeptide self-assembled nanoparticles. In doing so, we highlight the great advances made by the field, as well as the challenges still faced in achieving the clinical translation of peptide- and protein-functionalised nano-drug delivery vehicles, imaging species, and active therapeutics.